{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:42:15Z","timestamp":1785220935733,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.bmcl.2021.128522","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T21:52:54Z","timestamp":1640901174000},"page":"128522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Novel hydrazone derivatives of N-amino-11-azaartemisinin with high order of antimalarial activity against multidrug-resistant Plasmodium yoelii nigeriensis in Swiss mice via intramuscular route"],"prefix":"10.1016","volume":"58","author":[{"given":"Manvika","family":"Karnatak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hassam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit Shankar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil.K.","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ved Prakash","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2021.128522_b0005","unstructured":"World malaria report 2020. Geneva: World Health Organization, 2020."},{"key":"10.1016\/j.bmcl.2021.128522_b0010","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1126\/science.3887571","article-title":"Qinghaosu (artemisinin): an antimalarial drug from China","volume":"228","author":"Klayman","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2021.128522_b0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/med.2610070103","article-title":"The chemistry, pharmacology, and clinical applications of qinghaosu (artemisinin) and its derivatives","volume":"7","author":"Luo","year":"1987","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bmcl.2021.128522_b0020","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1128\/mr.60.2.301-315.1996","article-title":"Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy","volume":"60","author":"Meshnick","year":"1996","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.bmcl.2021.128522_b0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1054-3589(08)60952-7","article-title":"Antimalarial activity of artemisinin (qinghaosu) and related trioxanes","volume":"37","author":"Cumming","year":"1997","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bmcl.2021.128522_b0030","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3987\/REV-98-505","article-title":"Recent developments on the chemistry and biological activity of artemisinin and related antimalarials","volume":"51","author":"Bhattacharya","year":"1999","journal-title":"Heterocycles"},{"key":"10.1016\/j.bmcl.2021.128522_b0035","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0020-7519(02)00195-9","article-title":"Antimalarial chemotherapeutic peroxides: artemisinin, yingzhaosu A and related compounds","volume":"32","author":"Borstnik","year":"2002","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.bmcl.2021.128522_b0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.actatropica.2003.10.006","article-title":"Development of artemisinin and its structurally simplified trioxane derivatives as antimalarial drugs","volume":"89","author":"Ploypradith","year":"2004","journal-title":"Acta Trop."},{"key":"10.1016\/j.bmcl.2021.128522_b0045","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1021\/jm030571c","article-title":"A Medicinal chemistry perspective on artemisinin and related endoperoxides","volume":"47","author":"O\u2019Neill","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bmcl.2021.128522_b0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/med.10066","article-title":"Synthetic peroxides as antimalarials","volume":"24","author":"Tang","year":"2004","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bmcl.2021.128522_b0055","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.drudis.2007.04.009","article-title":"New development in synthetic peroxidic drugs as artemisinin mimics","volume":"12","author":"Jefford","year":"2007","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.bmcl.2021.128522_b0060","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.drudis.2009.05.008","article-title":"Progress in the development of peroxide-based antiparasitic agents","volume":"14","author":"Muraleedharan","year":"2009","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.bmcl.2021.128522_b0065","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1039\/B816679J","article-title":"Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents Chem","volume":"39","author":"Chaturvedi","year":"2010","journal-title":"Soc. Rev."},{"key":"10.1016\/j.bmcl.2021.128522_b0070","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro2331","article-title":"Artemisinin resistance: current status and scenarios for containment","volume":"8","author":"Dondrop","year":"2010","journal-title":"Nat Rev Microbiol."},{"key":"10.1016\/j.bmcl.2021.128522_b0075","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/QCO.0b013e32834cd3ed","article-title":"Recent clinical and molecular insight into emerging artemisinin resistance in Plasmodium falciparum","volume":"24","author":"O\u2019 Brien, C., Henrich, P. P., Passi, N., Fidlock, D.","year":"2011","journal-title":"Curr Opin Infected dis."},{"key":"10.1016\/j.bmcl.2021.128522_b0080","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ejmech.2018.12.007","article-title":"Current scenario of artemisinin and its analogues for antimalarial activity","volume":"163","author":"Kumari","year":"2019","journal-title":"Eur J Med Chem."},{"key":"10.1016\/j.bmcl.2021.128522_b0085","first-page":"1","article-title":"Current status of the artemisinin derivatives in the treatment of malaria with focus on arteether","volume":"211","author":"Asthana","year":"1997","journal-title":"J Parasitic Diseases"},{"key":"10.1016\/j.bmcl.2021.128522_b0090","first-page":"1960","article-title":"Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6","volume":"366","author":"Jambou","year":"2005","journal-title":"Res. Lett."},{"key":"10.1016\/j.bmcl.2021.128522_b0095","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1021\/jm0109816","article-title":"Mechanism-Based Design of Parasite-Targeted Artemisinin Derivatives: Synthesis and Antimalarial Activity of New Diamine Containing Analogues","volume":"45","author":"Hindley","year":"2002","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2021.128522_b0100","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1021\/jm020142z","article-title":"Structure-Activity Relationships of the Antimalarial Agent Artemisinin. Direct Modification of (+)-Artemisinin and in Vivo Antimalarial Screening of New, Potential Preclinical Antimalarial Candidates","volume":"45","author":"Avery","year":"2002","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2021.128522_b0105","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1021\/jm020461q","article-title":"Orally Active, Antimalarial, Anticancer, Artemisinin-Derived Trioxane Dimers with High Stability and Efficacy","volume":"46","author":"Posner","year":"2003","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2021.128522_b0110","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1021\/jm030947m","article-title":"Orally active Antimalarials: Hydrolytically stable derivatives of 10-Trifluromethyl Anhydrodihydroartemisinin","volume":"47","author":"Grellepois","year":"2004","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2021.128522_b0115","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1021\/jm058288w","article-title":"Second Generation, Orally Active, Antimalarial, Artemisinin-Derived Trioxane Dimers with High Stability, Efficacy, and Anticancer Activity","volume":"49","author":"Paik","year":"2006","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2021.128522_b0120","doi-asserted-by":"crossref","unstructured":"Rosenthal, A. S., Chen, X., Liu, J. O., West, D. C., Hergenrother, P. J., Shapiro, T. A.; and Posner G. H. Malaria-Infected Mice Are Cured by a Single Oral Dose of New Dimeric Trioxane Sulfones Which Are Also Selectively and Powerfully Cytotoxic to Cancer Cells. J Med Chem. 2009; 52:1198-1023.","DOI":"10.1021\/jm801484v"},{"key":"10.1016\/j.bmcl.2021.128522_b0125","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1021\/jm00026a011","article-title":"Structure-Activity Relationships of the Antimalarial Agent Artemisinin. 2. Effect of Heteroatom Substitution at O-11: Synthesis and Bioassay of N-Alkyl-11-aza-9-desmethylartemisinins","volume":"38","author":"Avery","year":"1995","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2021.128522_b0130","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0040-4039(94)02419-C","article-title":"Synthesis and Reactions of 11-Azaartemisinin and Derivatives","volume":"36","author":"Torok","year":"1995","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bmcl.2021.128522_b0135","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1021\/jm00026a012","article-title":"Synthesis and Antimalarial Activities of N-Substituted 11-Azaartemisinins","volume":"38","author":"Torok","year":"1995","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2021.128522_b0140","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/cmdc.200700065","article-title":"Preparation of N-Sulphonyl- and N-Carbonyl-11-Azaartemisinins with Greatly Enhanced Thermal Stabilities: in vitro Antimalarial Activities","volume":"2","author":"Haynes","year":"2007","journal-title":"Chem Med Chem."},{"key":"10.1016\/j.bmcl.2021.128522_b0145","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1021\/jacs.1c02249","article-title":"Marriage of Peroxides and Nitrogen Heterocycles: Selective Three-Component Assembly, Peroxide-Preserving Rearrangement, and Stereoelectronic Source of Unusual Stability of Bridged Azaozonides","volume":"143","author":"Yaremenko","year":"2021","journal-title":"J Am Chem Soc."},{"key":"10.1016\/j.bmcl.2021.128522_b0150","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1016\/j.tetlet.2014.07.027","article-title":"Synthesis of 11-aza-artemisinin derivatives using the Ugi reaction and an evaluation of their antimalarial activity","volume":"55","author":"Le","year":"2014","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bmcl.2021.128522_b0155","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1016\/j.bmc.2017.04.041","article-title":"Synthesis and anticancer activity of novel aza-artemisinin derivatives","volume":"25","author":"Jana","year":"2017","journal-title":"Bioorg Med Chem Lett."},{"key":"10.1016\/j.bmcl.2021.128522_b0160","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1021\/ol802238d","article-title":"Amino- and Hydroxy-Functionalized 11-Azaartemisinins and Their Derivatives","volume":"10","author":"Singh","year":"2008","journal-title":"Org Lett."},{"key":"10.1016\/j.bmcl.2021.128522_b0165","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1021\/jm401774f","article-title":"New Orally Active Amino- and Hydroxy-Functionalized 11- Azaartemisinins and Their Derivatives with High Order of Antimalarial Activity against Multidrug-Resistant Plasmodium yoelii in Swiss Mice","volume":"57","author":"Singh","year":"2014","journal-title":"J Med Chem."},{"key":"10.1016\/j.bmcl.2021.128522_b0170","unstructured":"The animals used for the present experiments were duly noted and approved by the Institutional Animal Ethics Committee of Central drug research institute (CDRI), Lucknow, UP, India and the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Government of India (a) Peters, W. Techniques for the study of drug response in experimental malaria. In Chemotherapy and drug resistance in malaria; Academic Press: London, 1970; pp 64-136. (b) In vivo test procedure: The colony bred Swiss mice (25 \u00b1 1g) were inoculated with 1X106 parasitized RBC on day zero and treatment was administered to a group of five mice at each dose, from day 0 to 3, in two divided doses daily. The drug dilution of compounds 10a-m were prepared in groundnut oil so as to contain the required amount of the drug (0.3 mg for a dose of 24 mg\/kg, 0.15 mg for a dose of 12 mg\/kg and 0.075 mg for a dose of 6 mg\/kg) in 0.1 ml and administered via oral and intramuscular routes for each dose. Parasitaemia level were recorded from thin blood smears on day 4 and subsequently twice a week till day 28. The treated mice surviving beyond day 28 were recorded as mice protected by the drug. mice treated with \u03b2 -arteether served as positive control."},{"key":"10.1016\/j.bmcl.2021.128522_b0175","unstructured":"(a) 100% suppression of parasitaemia means no parasites were detected in 50 oil immersion microscopic fields, parasites if at all presents were below the detection limit. The parasites present below the detection limit could multiply and eventually could be detected during observation on subsequent days. In such cases though the drug was providing near 100% suppression of the parasitaemia on day 4 but would not provide full protection to the treated mice in the 28 days survival assay. Multidrug-resistant Plasmodium yoelii nigeriensis used in this study is resistant to chloroquine, mefloquine and halofantrine. (b) 100% protection means all the treated mice survived till day 28. Similarly, 60% protection means three out of five treated mice survived till day 28."},{"key":"10.1016\/j.bmcl.2021.128522_b0180","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1006\/expr.1999.4465","article-title":"Azithromycin: antimalarial profile against blood and sporozoite-induced infections in mice and monkeys","volume":"94","author":"Puri","year":"2000","journal-title":"Expl Parasitol"},{"key":"10.1016\/j.bmcl.2021.128522_b0185","unstructured":"All compounds screened for their biological activity, the purity level of all compounds were above 99%."}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21007496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21007496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:43:09Z","timestamp":1760773389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X21007496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":37,"alternative-id":["S0960894X21007496"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128522","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel hydrazone derivatives of N-amino-11-azaartemisinin with high order of antimalarial activity against multidrug-resistant Plasmodium yoelii nigeriensis in Swiss mice via intramuscular route","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128522"}}